| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 24 | 24 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q2 2024 | 24 |
| SIMPLEX TRADING, LLC | 13 | 1 | 0.00% | 0.00% | 0.00% | Q1 2016 | Q2 2024 | 22 |
| GROUP ONE TRADING, L.P. | 6 | 1 | 0.00% | 0.00% | 0.01% | Q2 2015 | Q1 2024 | 19 |
| Citadel Advisors | 5 | 1 | 0.00% | 0.00% | 0.00% | Q2 2014 | Q4 2015 | 6 |
| JANE STREET GROUP, LLC | 4 | 4 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q1 2023 | 4 |
| JPMORGAN CHASE & CO | 2 | 1 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q2 2021 | 3 |
| Hudson Bay Capital Management LP | 2 | 2 | 0.02% | 0.03% | 0.03% | Q1 2017 | Q2 2017 | 2 |
This page lists all the filers that currently own THERAVANCE BIOPHARMA INC or have owned THERAVANCE BIOPHARMA INC in the past.